Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Baker

Showing results (941-950 of 990) with videos related to

Pageof 99
Sort By:
Virus Evolution|August 20, 2025
Experimental evidence of vaccine-driven evolution of respiratory syndrome virus type 2Nakarin Pamornchainavakul, Igor A D Paploski, Dennis N Makau, et al.
The Journal of Biological Chemistry|July 2, 2013
Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursorsSwarna Mehrotra, Bhumika Sharma, Sonali Joshi, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 29, 2004
The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infectionTim D Jones, Marian Hanlon, Beverley J Smith, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 8, 2002
Naltrexone in the treatment of alcohol dependence: a Canadian trialMyroslava K Romach, Edward M Sellers, Gail R Somer, et al.
Plos One|February 23, 2017
Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trialMandy Kader Konde, Darren P Baker, Fode Amara Traore, et al.
Nano Letters|May 3, 2021
Remarkably Weak Anisotropy in Thermal Conductivity of Two-Dimensional Hybrid Perovskite Butylammonium Lead Iodide CrystalsChen Li, Hao Ma, Tianyang Li, et al.
Molecular and Cellular Biology|October 7, 2009
Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signalingJianghuai Liu, Lucas P Carvalho, Sabyasachi Bhattacharya, et al.
The Journal of Biological Chemistry|October 18, 2012
Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responsesBhumika Sharma, Sonali Joshi, Antonella Sassano, et al.
Gastroenterology|April 21, 2001
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trialW J Sandborn, B G Feagan, S B Hanauer, et al.
Protein Science : a Publication of the Protein Society|January 7, 2010
Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinasesDouglas J Marcotte, Yu-Ting Liu, Robert M Arduini, et al.
Pageof 99

Showing results (941-950 of 990) with videos related to

Sort By:
Pageof 99
Virus Evolution|August 20, 2025
Experimental evidence of vaccine-driven evolution of respiratory syndrome virus type 2Nakarin Pamornchainavakul, Igor A D Paploski, Dennis N Makau, et al.
The Journal of Biological Chemistry|July 2, 2013
Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursorsSwarna Mehrotra, Bhumika Sharma, Sonali Joshi, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 29, 2004
The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infectionTim D Jones, Marian Hanlon, Beverley J Smith, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 8, 2002
Naltrexone in the treatment of alcohol dependence: a Canadian trialMyroslava K Romach, Edward M Sellers, Gail R Somer, et al.
Plos One|February 23, 2017
Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trialMandy Kader Konde, Darren P Baker, Fode Amara Traore, et al.
Nano Letters|May 3, 2021
Remarkably Weak Anisotropy in Thermal Conductivity of Two-Dimensional Hybrid Perovskite Butylammonium Lead Iodide CrystalsChen Li, Hao Ma, Tianyang Li, et al.
Molecular and Cellular Biology|October 7, 2009
Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signalingJianghuai Liu, Lucas P Carvalho, Sabyasachi Bhattacharya, et al.
The Journal of Biological Chemistry|October 18, 2012
Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responsesBhumika Sharma, Sonali Joshi, Antonella Sassano, et al.
Gastroenterology|April 21, 2001
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trialW J Sandborn, B G Feagan, S B Hanauer, et al.
Protein Science : a Publication of the Protein Society|January 7, 2010
Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinasesDouglas J Marcotte, Yu-Ting Liu, Robert M Arduini, et al.
Pageof 99